Quantitative proton MRS of Pelizaeus–Merzbacher disease
- 13 September 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 65 (5), 701-706
- https://doi.org/10.1212/01.wnl.0000174642.32187.20
Abstract
Background: Pelizaeus–Merzbacher disease (PMD) is a rare X-linked recessive neurologic disorder caused by a mutation in the proteolipid protein (PLP) gene on chromosome Xq22. The associated depletion of PLP and severe reduction of other major myelin proteins results in dysmyelination. MRI reveals loss of T1 contrast between gray and affected white matter and T2 hyperintensities of white matter due to elevated water content. Methods: In vivo proton magnetic resonance spectroscopy (MRS) was used to determine cerebral metabolite patterns in five patients with genetically proven PMD. Absolute metabolite concentrations were obtained in cortical gray matter, affected white matter, and basal ganglia and compared to age-matched control values. Results: In comparison to age-matched controls, MRS of affected white matter resembled the metabolite pattern of cortical gray matter, as indicated by increased concentrations of N-acetylaspartate and N-acetylaspartylglutamate (tNAA), glutamine (Gln), myo-inositol (Ins), and creatine and phosphocreatine. Most remarkably, the concentration of choline-containing compounds was reduced. Parietal gray matter and basal ganglia appeared normal but showed a tendency for elevated tNAA, Gln, and Ins. Conclusions: Magnetic resonance spectroscopy (MRS)–detected alterations are consistent with enhanced neuroaxonal density, astrogliosis, and reduction of oligodendroglia. These disturbances in cellular composition are in close agreement with the histopathologic features characteristic of dys- and hypomyelination. The proton MRS profile of Pelizaeus–Merzbacher disease (PMD) differs from the pattern commonly observed in demyelinating disorders and allows PMD to be distinguished from other leukodystrophies.Keywords
This publication has 27 references indexed in Scilit:
- MR spectroscopy in pediatric white matter diseasePublished by Cambridge University Press (CUP) ,2004
- Mutations in the Gene Encoding Gap Junction Protein α12 (Connexin 46.6) Cause Pelizaeus-Merzbacher–Like DiseaseAmerican Journal of Human Genetics, 2004
- Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy Before and After Hematopoietic Stem Cell TransplantationNeuropediatrics, 2003
- Degree of Hypomyelination and Magnetic Resonance Spectroscopy Findings in Patients with Pelizaeus Merzbacher PhenotypeNeuropediatrics, 2003
- A PLP splicing abnormality is associated with an unusual presentation of PMDAnnals of Neurology, 2002
- Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changesFEBS Letters, 2001
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal CellsDevelopmental Neuroscience, 1993
- Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; Myo‐inositol and related metabolitesNMR in Biomedicine, 1991
- N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brainNeuroscience & Biobehavioral Reviews, 1989